Patents by Inventor Anthony W. Czarnik

Anthony W. Czarnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11918567
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: March 5, 2024
    Assignee: Poxel SA
    Inventor: Anthony W. Czarnik
  • Patent number: 11298317
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: April 12, 2022
    Assignee: Deuteria Beverages, LLC
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • Publication number: 20220000851
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 3, 2021
    Publication date: January 6, 2022
    Inventor: Anthony W. Czarnik
  • Patent number: 10940143
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: March 9, 2021
    Assignee: Poxel SA
    Inventor: Anthony W. Czarnik
  • Publication number: 20210038511
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Application
    Filed: July 29, 2020
    Publication date: February 11, 2021
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • Patent number: 10731116
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: August 4, 2020
    Assignee: Deuteria Beverages, LLC
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • Publication number: 20200179360
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 5, 2019
    Publication date: June 11, 2020
    Inventor: Anthony W. Czarnik
  • Patent number: 10576071
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: March 3, 2020
    Assignee: Poxel SA
    Inventor: Anthony W. Czarnik
  • Publication number: 20190062680
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Application
    Filed: August 14, 2018
    Publication date: February 28, 2019
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • Publication number: 20190008842
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: March 12, 2018
    Publication date: January 10, 2019
    Inventor: Anthony W. Czarnik
  • Patent number: 10058095
    Abstract: The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a compound of structure 1: wherein: there are at least 6×1018 molecules of the aldehyde and Rx is hydrogen, wherein the deuterium isotope in Rx is in an amount greater than 0.10 percent of the hydrogen atoms present in Rx.
    Type: Grant
    Filed: July 23, 2017
    Date of Patent: August 28, 2018
    Assignee: Deuteria Agrochemicals, LLC
    Inventor: Anthony W Czarnik
  • Patent number: 10047330
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: August 14, 2018
    Assignee: Deuterla Beverages, LLC
    Inventors: Anthony W Czarnik, Jeffrey A McKinney
  • Patent number: 9925175
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: March 27, 2018
    Assignee: DeuteRx, LLC
    Inventor: Anthony W. Czarnik
  • Publication number: 20180042229
    Abstract: The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a compound of structure 1: wherein: there are at least 6×1018 molecules of the aldehyde and Rx is hydrogen, wherein the deuterium isotope in Rx is in an amount greater than 0.10 percent of the hydrogen atoms present in Rx.
    Type: Application
    Filed: July 23, 2017
    Publication date: February 15, 2018
    Inventor: Anthony W. Czarnik
  • Publication number: 20180030394
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Application
    Filed: August 14, 2017
    Publication date: February 1, 2018
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • Patent number: 9732311
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Grant
    Filed: May 31, 2015
    Date of Patent: August 15, 2017
    Assignee: DEUTERIA BEVERAGES, LLC
    Inventors: Anthony W Czarnik, Jeffrey A McKinney
  • Patent number: 9713330
    Abstract: The present invention generally relates to deuterium-enriched aldehydes, compositions comprising deuterium-enriched aldehydes, and methods for slowing the rate of aldehyde autoxidation. In one aspect, the present invention provides a composition comprising a compound of structure 1: wherein: there are at least 6×1018 molecules of the aldehyde and Rx is hydrogen, wherein the deuterium isotope in Rx is in an amount greater than 0.10 percent of the hydrogen atoms present in Rx.
    Type: Grant
    Filed: October 29, 2015
    Date of Patent: July 25, 2017
    Assignee: DEUTERIA AGROCHEMICALS, LLC
    Inventor: Anthony W Czarnik
  • Publication number: 20160362733
    Abstract: The invention relates to compositions and methods for multiplex decoding of microsphere array sensors.
    Type: Application
    Filed: June 21, 2016
    Publication date: December 15, 2016
    Inventors: Mark S. Chee, John R. Stuelpnagel, Anthony W. Czarnik
  • Publication number: 20160354355
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: April 1, 2016
    Publication date: December 8, 2016
    Inventor: Anthony W. Czarnik
  • Patent number: 9399795
    Abstract: The invention relates to compositions and methods for multiplex decoding of microsphere array sensors.
    Type: Grant
    Filed: July 2, 2014
    Date of Patent: July 26, 2016
    Assignee: ILLUMINA, INC.
    Inventors: Mark S. Chee, John R. Stuelpnagel, Anthony W. Czarnik